Four Tests, One Result
We offer four state-of-the-art tests: Molecular Identification, Molecular Antibiotic Gene Resistance, Antibiotic Sensitivity Testing, iQ Ab Guide
Industry Leading Testing
iQ Genetix Testing Capabilities
Molecular UTI Panel
Urinary tract infections are among the most common types of illnesses among all ages. Each year, around 150 million people are affected by symptomatic or asymptomatic urinary tract infections, which could present serious health issues.
What Seperates Our Tests
Currently, UTIs are diagnosed by clinical symptoms, urine analysis and bacterial culture, and are often treated with broad spectrum antibiotics. However, the urinary tract hosts a diverse and complex microbial community, and some of those organisms can be difficult to culture. Emerging evidence shows that urinary tract microbiota may exert profound effects on urinary tract health, both positive and negative. Traditional culture-based or microscopy- based methods for investigation of urinary tract microbiota can lack sensitivity and specificity; they can also be subjective, time-consuming, and inaccurate.
Interactive Antibiotic Guide for Molecular UTI Panel
We discover, develop, and market a transformative molecular diagnostic test that addresses pressing clinical needs across multiple medical specialties. Using state-of-the-art analytical equipment, automated specimen processing and advanced reporting applications.
Integrated into an Antibiotic Stewardship program is the perfect solution in helping clinicians quickly decide:
An intelligent molecular based diagnostic solution that is routinely updated with the latest molecular and antibiotic information. This is a unique, data-driven approach that combines precise, molecular pathogen and resistance gene detection with sensitivity and susceptibility data (Sanford Guide®).
Supports clinicians in providing a more targeted and customized treatment plan through pharmacy guidance for their patients within 24 hours of the patient sample arriving at our lab. This guidance may consider the patient’s age, comorbidities, allergies, concomitant medications, regional susceptibility patterns in addition to the test results.
Molecular STI Panel
Sexually transmitted infections are diseases caused by microorganisms and viral infections that spread through sexual contact. When diagnosed in the early stages, many STIs can be easily treated and cured. STIs that remain undiagnosed or untreated can have serious health consequences. Individuals who are asymptotic are still at risk of long-term complications and can still spread the infection. For these reasons, it is important every sexually active individual be screened for STIs.
Chlamydia trachomatis and Neisseria gonorrhea are the two most common sexually transmitted infections. Currently, testing relies on culture, which takes at least 48 hours.
Current STI testing relies on lab culture to identify infections and any drug resistance. This takes at least 48 hours. In the meantime, the patient is prescribed a first-line antibiotic treatment. Pathogens resistant to these antibiotics can result in an ineffective first treatment.
Untreated or inappropriately treated STIs can lead to a range of secondary complications including pelvic inflammatory disease, infertility, complications in pregnancy, reproductive system cancers,
the enhanced transmission of HIV, and epididymitis. The emergence of drug-resistant strains of STI such as gonorrhea is also causing considerable global concern.
Up to 52% of women will be over-diagnosed with a UTI when visiting emergency departments with traditional UTI symptoms
Up to 50% of women diagnosed with a UTI will have a positive culture and 10-50% will have a STI
Over 37% of women will be underdiagnosed with an STI when visiting emergency departments with traditional UTI symptoms
COVID-19 PCR Test
Respiratory Pathogen Panel
The Respiratory Pathogen Panel quickly detects and differentiates viral and bacterial pathogens so effective treatment can begin sooner
The Respiratory Pathogen Panel utilizes quantitative Real-Time PCR to analyze your patient’s nasal sample and reports results in the same to 24 hours. The test precisely identifies 16 respiratory viruses and bacterial species, including Coronavirus from a single specimen. Same day to 24-hour turnaround time, preventing delays in diagnosis and treatment
Gastrointestinal Pathogen Panel
Clinical Utility of molecular diagnostic testing is recognized by the American College of Gastroenterology:
“Several well-designed studies show that molecular testing now surpasses all other approaches for the routine diagnosis of diarrhea. Molecular diagnostic tests can provide a more comprehensive assessment of disease etiology by increasing the diagnostic yield compared with conventional diagnostic tests. They are also faster, providing results in hours rather than days.”
Genetic testing is a proven valuable tool for physicians caring for individuals with severe symptoms, have weakened immune system and/or those with advanced age.
Stool cultures have been the standard diagnostic tool for determining the microbial etiology of suspected bacterial infectious diarrhea, however, they are time consuming and have low positive.
Multiplex molecular testing has emerged as valid, fast and accurate diagnostic tool for acute infectious gastroenteritis.
Wound Pathogen Panel
Wound management can be complicated due to polymicrobial organisms and antibiotic resistance.
Multi-layered microbial communities, known as biofilms, surrounded by a self-produced protective extracellular slime further complicate a diagnosis. More fastidious organisms may not be identified with standard culture, resulting in a delay in the appropriate treatment.
Additionally, the acquisition or emergence of resistance among bacteria that infect or colonize these wounds is a major health concern according to the CDC and the World Health Organization.